Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).

Author: Bonaca, Marc P. MD, MPH; Nault, Patrice MD; Giugliano, Robert P. MD, SM; Keech, Anthony C. MD; Pineda, Armando Lira MD; Kanevsky, Estella MS; Kuder, Julia MA; Murphy, Sabina A. MPH; Jukema, J. Wouter MD, PhD; Lewis, Basil S. MD; Tokgozoglu, Lale MD; Somaratne, Ransi MD; Sever, Peter S. PhD; Pedersen, Terje R. MD; Sabatine, Marc S. MD, MPH

Page: 338-350

http://ift.tt/2BkC4OA